Physician-led consortium signs first deal for generics manufacturing

Civica Rx has inked a supply deal with Danish firm Xellia Pharmaceuticals for the manufacture of essential generic antibiotics, including vancomycin and daptomycin, for Civica’s member health systems.

Civica is a US-based generics company,  founded in 2018 by a group of hospitals with the aim of bypassing high drug prices in the US healthcare system.

As well as reducing costs, the group announced an intention to make supplies of medicines more predictable, starting with 14 therapies, mainly injectables, that are on the US Food and Drug Administration’s drugs shortage list.